Terms ending in 2033
Every in-force patent on Kymab Limited's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,788,534 | Animal Models and Therapeutic Molecules In force · High confidence | Kymab Limited | In force | High confidence | |
| US 10,226,033 | Animal Models and Therapeutic Molecules In force · High confidence | Kymab Limited | In force | High confidence | |
| US 10,730,930 | Antibodies, Variable Domains & Chains Tailored for Human Use In force · High confidence | Kymab Limited | In force | High confidence | |
| US 11,820,810 | Antibodies, Variable Domains and Chains Tailored for Human Use In force · High confidence | Kymab Limited | In force | High confidence | |
| US 8,883,157 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| US 8,951,523 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| US 8,999,341 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| US 9,034,331 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| US 9,034,332 | Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| US 9,040,052 | Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | |
| 7 more term ends in 2033 · Pro | |||||
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.